Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.

Griffin NE, Buchanan TR, Smith SH, Leon AA, Meyer MF, Liu J, Tabak RG, Fuh KC, Thaker PH, Powell MA, Mutch DG, Massad LS, Colditz GA, Hagemann AR.

Gynecol Oncol. 2019 Nov 25. pii: S0090-8258(19)31626-9. doi: 10.1016/j.ygyno.2019.11.005. [Epub ahead of print]

PMID:
31780235
2.

A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer.

Moore KN, Miller A, Bell-McGuinn KM, Schilder RJ, Walker JL, O'Cearbhaill RE, Guntupalli SR, Armstrong DK, Hagemann AR, Gray HJ, Duska LR, Mathews CA, Chen A, O'Malley D, Gordon S, Fracasso PM, Aghajanian C.

Gynecol Oncol. 2019 Nov 7. pii: S0090-8258(19)31569-0. doi: 10.1016/j.ygyno.2019.10.012. [Epub ahead of print]

PMID:
31708167
3.

Optical Resolution Photoacoustic Microscopy of Ovary and Fallopian Tube.

Rao B, Leng X, Zeng Y, Lin Y, Chen R, Zhou Q, Hagemann AR, Kuroki LM, McCourt CK, Mutch DG, Powell MA, Hagemann IS, Zhu Q.

Sci Rep. 2019 Oct 4;9(1):14306. doi: 10.1038/s41598-019-50743-7.

4.

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.

Coleman RL, Fleming GF, Brady MF, Swisher EM, Steffensen KD, Friedlander M, Okamoto A, Moore KN, Efrat Ben-Baruch N, Werner TL, Cloven NG, Oaknin A, DiSilvestro PA, Morgan MA, Nam JH, Leath CA 3rd, Nicum S, Hagemann AR, Littell RD, Cella D, Baron-Hay S, Garcia-Donas J, Mizuno M, Bell-McGuinn K, Sullivan DM, Bach BA, Bhattacharya S, Ratajczak CK, Ansell PJ, Dinh MH, Aghajanian C, Bookman MA.

N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909707. [Epub ahead of print]

PMID:
31562800
5.

Patients with endometrial cancer continue to lack understanding of their risks for cancer.

Sekhon S, Massad LS, Hagemann AR, Dick R, Leon A, Zamorano AS, Thaker PH, McCourt CK, Mutch DG, Powell MA, Kuroki LM.

Gynecol Oncol Rep. 2019 Aug 10;29:106-110. doi: 10.1016/j.gore.2019.07.013. eCollection 2019 Aug.

6.

Pre-diagnosis body mass index, physical activity and ovarian cancer mortality.

Zamorano AS, Hagemann AR, Morrison L, Lee JA, Liao LM, Brinton LA, Park Y, Toriola AT.

Gynecol Oncol. 2019 Oct;155(1):105-111. doi: 10.1016/j.ygyno.2019.07.025. Epub 2019 Aug 2.

PMID:
31383570
7.

Histogram analysis of en face scattering coefficient map predicts malignancy in human ovarian tissue.

Zeng Y, Nandy S, Rao B, Li S, Hagemann AR, Kuroki LK, McCourt C, Mutch DG, Powell MA, Hagemann IS, Zhu Q.

J Biophotonics. 2019 Nov;12(11):e201900115. doi: 10.1002/jbio.201900115. Epub 2019 Aug 5.

PMID:
31304678
8.

SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients.

Husen P, Straub K, Willuweit K, Hagemann A, Wedemeyer H, Bachmann HS, Herzer K.

Transplant Proc. 2019 Jul - Aug;51(6):1962-1971. doi: 10.1016/j.transproceed.2019.03.027. Epub 2019 Jul 11.

PMID:
31303410
9.

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?

Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM.

Gynecol Oncol Rep. 2019 Apr 24;28:136-140. doi: 10.1016/j.gore.2019.04.007. eCollection 2019 May.

10.

Wound Complication Rates After Vulvar Excisions for Premalignant Lesions.

Mullen MM, Merfeld EC, Palisoul ML, Massad LS, Woolfolk C, Powell MA, Mutch DG, Thaker PH, Hagemann AR, Kuroki LM.

Obstet Gynecol. 2019 Apr;133(4):658-665. doi: 10.1097/AOG.0000000000003185.

PMID:
30870300
11.

Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?

Cripe JC, Buchanan TR Jr, Wan L, Hagemann AR, McCourt CK, Massad LS, Fuh KC, Mutch DG, Powell MA, Thaker PH, Kuroki LM.

Gynecol Oncol Rep. 2019 Jan 26;28:1-5. doi: 10.1016/j.gore.2019.01.005. eCollection 2019 May.

12.

Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.

Cripe JC, Buchanan TR Jr, Kuroki LM, Wan L, Mills KA, Massad L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Matsuo K, Thaker PH.

Gynecol Oncol. 2019 Apr;153(1):123-126. doi: 10.1016/j.ygyno.2019.01.009. Epub 2019 Jan 14.

PMID:
30651188
13.

Posterior epidural migration of herniated lumbar disc fragment: a literature review.

Elsharkawy AE, Hagemann A, Klassen PD.

Neurosurg Rev. 2019 Dec;42(4):811-823. doi: 10.1007/s10143-018-01065-1. Epub 2019 Jan 6. Review.

PMID:
30613923
14.

Acute and sub-lethal effects of an anionic polyacrylamide on sensitive early life stages of Atlantic cod (Gadus morhua).

Hansen BH, Malzahn A, Hagemann A, Farkas J, Skancke J, Altin D, Nordtug T.

Sci Total Environ. 2019 Feb 20;652:1062-1070. doi: 10.1016/j.scitotenv.2018.10.310. Epub 2018 Oct 24.

PMID:
30586793
15.

Obesity counseling in obstetrics and gynecology: provider perceptions and barriers.

Huepenbecker SP, Wan L, Leon A, Rosen D, Hoff J, Kuroki LM, Fuh KC, Powell MA, Mutch DG, Colditz GA, Hagemann AR.

Gynecol Oncol Rep. 2018 Dec 10;27:31-34. doi: 10.1016/j.gore.2018.12.001. eCollection 2019 Feb. French.

16.

Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.

Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2019 Feb;18(2):389-398. doi: 10.1158/1535-7163.MCT-18-0537. Epub 2018 Nov 26.

PMID:
30478151
17.

SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.

Mills KA, Roach ST, Quinn JM, Guo L, Beck HM, Lomonosova E, Ilivicky AR, Starks CM, Lawrence JA, Hagemann AR, McCourt C, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Gynecol Oncol. 2018 Nov;151(2):337-344. doi: 10.1016/j.ygyno.2018.08.008. Epub 2018 Sep 3.

18.

Gynecologic Oncologists' Perceptions of Palliative Care and Associated Barriers: A Survey of the Society of Gynecologic Oncology.

Cripe JC, Mills KA, Kuroki LK, Wan L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Thaker PH.

Gynecol Obstet Invest. 2019;84(1):50-55. doi: 10.1159/000491089. Epub 2018 Aug 10. Review.

PMID:
30099446
20.

Psychometric evaluation of the Epilepsy-related Fears in Parents Questionnaire.

Hagemann A, Pfäfflin M, Nussbeck FW, May TW.

Epilepsy Behav. 2018 Jun;83:201-206. doi: 10.1016/j.yebeh.2018.03.030. Epub 2018 May 1.

PMID:
29723797
21.

Defining and mitigating the challenges of an older and obese population in minimally invasive gynecologic cancer surgery.

Hagemann AR, McCourt CK, Varaday SS, Moore KN.

Gynecol Oncol. 2018 Mar;148(3):601-608. doi: 10.1016/j.ygyno.2017.12.020. Epub 2018 Jan 10. Review.

PMID:
29329881
22.

Cervical clear cell adenocarcinoma with an exceptionally low proliferation index: Report of a case.

Dandulakis MG, Mattis AJ, Hagemann AR, Hagemann IS.

Gynecol Oncol Rep. 2018 Jan 2;23:16-19. doi: 10.1016/j.gore.2017.12.006. eCollection 2018 Feb.

23.

A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors.

Haggerty AF, Hagemann A, Barnett M, Thornquist M, Neuhouser ML, Horowitz N, Colditz GA, Sarwer DB, Ko EM, Allison KC.

Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S102-S108. doi: 10.1002/oby.22021.

24.

Exploring the putative self-binding property of the human farnesyltransferase alpha-subunit.

Hagemann A, Müller G, Manthey I, Bachmann HS.

FEBS Lett. 2017 Nov;591(21):3637-3648. doi: 10.1002/1873-3468.12862. Epub 2017 Oct 11.

25.

Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.

Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS.

Gynecol Oncol. 2017 Nov;147(2):309-314. doi: 10.1016/j.ygyno.2017.08.031. Epub 2017 Sep 13.

PMID:
28916118
26.

Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.

Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2017 Dec;16(12):2881-2891. doi: 10.1158/1535-7163.MCT-17-0587. Epub 2017 Sep 13.

27.

The effect of a multidisciplinary palliative care initiative on end of life care in gynecologic oncology patients.

Mullen MM, Divine LM, Porcelli BP, Wilkinson-Ryan I, Dans MC, Powell MA, Mutch DG, Hagemann AR, Thaker PH.

Gynecol Oncol. 2017 Nov;147(2):460-464. doi: 10.1016/j.ygyno.2017.08.002. Epub 2017 Aug 4.

PMID:
28784245
28.

Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.

Kuroki LM, Mullen MM, Massad LS, Wu N, Liu J, Mutch DG, Powell MA, Hagemann AR, Thaker PH, McCourt CK, Novetsky AP.

Obstet Gynecol. 2017 Jul;130(1):91-99. doi: 10.1097/AOG.0000000000002061.

29.

Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.

Ioffe YJ, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW.

Gynecol Obstet Invest. 2018;83(1):83-89. doi: 10.1159/000458706. Epub 2017 Apr 8.

PMID:
28399524
30.

Kinetic Requirements for Spatiotemporal Chemical Imaging with Fluorescent Nanosensors.

Meyer D, Hagemann A, Kruss S.

ACS Nano. 2017 Apr 25;11(4):4017-4027. doi: 10.1021/acsnano.7b00569. Epub 2017 Apr 10.

PMID:
28379687
31.

A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

Jandial DA, Brady WE, Howell SB, Lankes HA, Schilder RJ, Beumer JH, Christner SM, Strychor S, Powell MA, Hagemann AR, Moore KN, Walker JL, DiSilvestro PA, Duska LR, Fracasso PM, Dizon DS.

Gynecol Oncol. 2017 May;145(2):236-242. doi: 10.1016/j.ygyno.2017.03.013. Epub 2017 Mar 22.

32.

AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.

Divine LM, Nguyen MR, Meller E, Desai RA, Arif B, Rankin EB, Bligard KH, Meyerson C, Hagemann IS, Massad M, Thaker PH, Hagemann AR, McCourt CK, Powell MA, Mutch DG, Fuh KC.

Oncotarget. 2016 Nov 22;7(47):77291-77305. doi: 10.18632/oncotarget.12637.

33.

The efficacy of an educational program for parents of children with epilepsy (FAMOSES): Results of a controlled multicenter evaluation study.

Hagemann A, Pfäfflin M, Nussbeck FW, May TW.

Epilepsy Behav. 2016 Nov;64(Pt A):143-151. doi: 10.1016/j.yebeh.2016.09.027. Epub 2016 Oct 13.

34.

The effect of college education on mortality.

Buckles K, Hagemann A, Malamud O, Morrill M, Wozniak A.

J Health Econ. 2016 Dec;50:99-114. doi: 10.1016/j.jhealeco.2016.08.002. Epub 2016 Sep 3.

PMID:
27723470
35.

A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome.

Kedor C, Zernicke J, Hagemann A, Gamboa LM, Callhoff J, Burmester GR, Feist E.

Clin Rheumatol. 2016 Sep;35(9):2203-10. doi: 10.1007/s10067-016-3360-4. Epub 2016 Jul 28.

PMID:
27470087
36.

Secreted Frizzled-related Protein 2 (sFRP2) Redirects Non-canonical Wnt Signaling from Fz7 to Ror2 during Vertebrate Gastrulation.

Brinkmann EM, Mattes B, Kumar R, Hagemann AI, Gradl D, Scholpp S, Steinbeisser H, Kaufmann LT, Özbek S.

J Biol Chem. 2016 Jun 24;291(26):13730-42. doi: 10.1074/jbc.M116.733766. Epub 2016 Apr 29.

37.

Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Divine LM, Kizer NT, Hagemann AR, Pittman ME, Chen L, Powell MA, Mutch DG, Rader JS, Thaker PH.

Gynecol Oncol. 2016 Jul;142(1):76-82. doi: 10.1016/j.ygyno.2016.04.030. Epub 2016 May 8.

38.

Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics.

Aranake-Chrisinger J, Huettner PC, Hagemann AR, Pfeifer JD.

Hum Pathol. 2016 Jun;52:92-100. doi: 10.1016/j.humpath.2016.01.005. Epub 2016 Feb 4.

PMID:
26980014
39.

Obesity Education Strategies for Cancer Prevention in Women's Health.

Liu L, Segura A, Hagemann AR.

Curr Obstet Gynecol Rep. 2015 Dec 1;4(4):249-258. Epub 2015 Oct 13.

40.

Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery.

Corr BR, Winter AM, Sammel MD, Chu CS, Gage BF, Hagemann AR.

Gynecol Oncol. 2015 Sep;138(3):501-6. doi: 10.1016/j.ygyno.2015.07.017. Epub 2015 Jul 14.

41.

Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer.

Kuroki LM, Benn TE, Dukes JL, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I.

Gynecol Oncol Rep. 2015 Apr;12:41-44.

42.

Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.

Frolova AI, Babb SA, Zantow E, Hagemann AR, Powell MA, Thaker PH, Gao F, Mutch DG.

Gynecol Oncol. 2015 Apr;137(1):7-13. doi: 10.1016/j.ygyno.2015.01.535. Epub 2015 Jan 21.

43.

Filopodia-based Wnt transport during vertebrate tissue patterning.

Stanganello E, Hagemann AI, Mattes B, Sinner C, Meyen D, Weber S, Schug A, Raz E, Scholpp S.

Nat Commun. 2015 Jan 5;6:5846. doi: 10.1038/ncomms6846.

PMID:
25556612
44.

Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.

Chen Q, Su Y, Wesslowski J, Hagemann AI, Ramialison M, Wittbrodt J, Scholpp S, Davidson G.

EMBO Rep. 2014 Dec;15(12):1254-67. doi: 10.15252/embr.201439644. Epub 2014 Nov 12.

45.

Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.

Wilkinson-Ryan I, Frolova AI, Liu J, Stewart Massad L, Thaker PH, Powell MA, Mutch DG, Hagemann AR.

Int J Gynecol Cancer. 2015 Jan;25(1):63-8. doi: 10.1097/IGC.0000000000000321.

46.

Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses.

Haggerty AF, Hagemann AR, Chu C, Siegelman ES, Rubin SC.

Int J Gynecol Cancer. 2014 Sep;24(7):1215-21. doi: 10.1097/IGC.0000000000000203.

PMID:
25153677
47.

In vivo analysis of formation and endocytosis of the Wnt/β-catenin signaling complex in zebrafish embryos.

Hagemann AI, Kurz J, Kauffeld S, Chen Q, Reeves PM, Weber S, Schindler S, Davidson G, Kirchhausen T, Scholpp S.

J Cell Sci. 2014 Sep 15;127(Pt 18):3970-82. doi: 10.1242/jcs.148767. Epub 2014 Jul 29. Erratum in: J Cell Sci. 2014 Dec 15;127(24):5331.

48.

A case of ovarian cancer metastases causing a symptomatic paraesophageal hernia.

Wolfe M, Wilkinson-Ryan I, Hagemann AR, Thaker PH.

Am J Obstet Gynecol. 2014 Nov;211(5):568.e1-2. doi: 10.1016/j.ajog.2014.07.040. Epub 2014 Jul 25. No abstract available.

PMID:
25068565
49.

A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients.

Novetsky AP, Zighelboim I, Guntupalli SR, Ioffe YJ, Kizer NT, Hagemann AR, Powell MA, Thaker PH, Mutch DG, Massad LS.

Gynecol Oncol. 2014 Aug;134(2):233-7. doi: 10.1016/j.ygyno.2014.06.012. Epub 2014 Jun 18.

50.

Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.

Wilkinson-Ryan I, Binder PS, Pourabolghasem S, Al-Hammadi N, Fuh K, Hagemann A, Thaker P, Schwarz J, Grigsby P, Mutch D, Powell M.

Gynecol Oncol. 2014 Jul;134(1):24-8. doi: 10.1016/j.ygyno.2014.05.002. Epub 2014 May 10.

PMID:
24823648

Supplemental Content

Loading ...
Support Center